Alluvi Healthcare – Advanced Wellness & Precision Health Solutions
Alluvi..Redefining Modern Healthcare with Science & Innovation
-
Uncategorized
Alluvi Retatrutide 20mg 2x bundle
Price range: £90.00 through £320.00 Select options This product has multiple variants. The options may be chosen on the product page
About us
RETATRUTIDE – PRE-FILLED PEN EVALUATION
Part of Labs’ ongoing research program into advanced GLP-1 multi-agonist compounds.
This formulation is supplied in controlled batches for laboratory analysis of stability, compound behaviour, and injector system performance.
Not for human or veterinary consumption.
of stability, compound behaviour, and injector system performance.
Not for human or veterinary consumption.
TRACK. DOSE. PROGRESS.
The Alluvi app supports wellness goals with smart tracking, log nutrition, monitor weight, and stay consistent through a modern mobile dashboard.
RECOVERY MEETS ROUTINE
Daily gummy supplements crafted for sleep, stress support, and muscle recovery, for rest and protein for strength, all in a clean, delicious form.
POWER-UP IN A GUMMY
A delicious way to fuel your body with protein and creatine – Alluvi Gummy Bears are a quick, convenient solution to stay on top of daily nutrients. No scoops. No shakes. Just results.
PROVEN DATA. BACKED BY RESEARCH.
Published studies have investigated GLP-1 multi-agonist compounds under controlled conditions.
Peptide supplies Retatrutide pens exclusively for laboratory research and development.
Not for human or veterinary consumption.
All figures are derived from third party published studies and are shown only for academic context. All Alluvi products are supplied strictly for laboratory research purposes.
22.5%
Reference value drawn from published research on GLP-1 multi-agonist compounds.
Provided strictly as scientific context.
Participants consumed fewer calories per day without being instructed to diet – driven by decreased appetite and satiety signaling.
Provided strictly as scientific context.
28%
Reported value in published research relating to GLP-1 multi-agonist compounds.
Provided strictly as a scientific reference point
18.3 KG
Average weight loss during clinical trial period of 48 weeks on high-dose Retatrutide.
Example data point referenced in peer-reviewed studies for GLP-1 multi-agonists.
it does not promote or imply medical use of its product